Related Experiment Videos
Targeting T cell killing with complement component C3-anti CD3 fusion proteins
W Fecke1, M Koukidou, T C Farries
1Imutran Ltd (A Novartis Pharma AG Company), Cambridge, United Kingdom.
Transplantation Proceedings
|September 2, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Convergent evolution of pain-inducing defensive venom components in spitting cobras.
Science (New York, N.Y.)·2021
Modeling observations of solar coronal mass ejections with heliospheric imagers verified with the Heliophysics System Observatory.
Space weather : the international journal of research & applications·2017
Isolation and characterization of renin-like aspartic-proteases from Echis ocellatus venom.
Toxicon : official journal of the International Society on Toxinology·2017
CXCR4 Antagonists: A Screening Strategy for Identification of Functionally Selective Ligands.
Journal of biomolecular screening·2014
Practical applications of insects' sexual development for pest control.
Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation·2014
Heart Transplantation in Brazil: Two Decades of Gender Disparities in the World's Largest Public Organ Transplant System.
Transplantation proceedings·2026
Acute Rejection Mediated by Preformed Anti-HLA-C Antibody in a Kidney Transplant Patient: A Case Report.
Transplantation proceedings·2026
Liver Transplantation for Metastatic Neuroendocrine Tumors: A Single-Center Experience in a Brazilian Referral Center.
Transplantation proceedings·2026
Statistical analysis plan considerations for autologous cell and cell-based gene therapy clinical trials.
Journal of biopharmaceutical statistics·2026
Nanosensitive optical coherence tomography to monitor corneal burn and treatment response in vivo.
Biomedical optics express·2026
Contemporary perspectives on metabolic surgery for type 2 diabetes: surgical techniques, outcomes, and complications.
Frontiers in endocrinology·2026